1.
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
2.
3.
4.
5.
Novel and recurrent PITX3 mutations in Belgian families with autosomal dominant congenital cataract and anterior segment dysgenesis have similar phenotypic and functional character...
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
La recherche médicale, une aventure de l'imagination au feu des besoins :plaidoyer en faveur d'un fonds interuniversitaire d'investigation pharmacologique